Skip to Content
Merck
  • [Clinical study on effect of yuantong capsule in treating vascular dementia].

[Clinical study on effect of yuantong capsule in treating vascular dementia].

Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine (2003-12-12)
Jun-shan Huang, Qiu-cheng Lin, Rong-zhang Huang
ABSTRACT

To observe the clinical effect of Yuantong Capsule (YTC) in treating vascular dementia (VD). Eighty-three patients of VD were randomized on ratio of 2:1 into two groups, the 54 patients in the treated group were treated with YTC orally administered, 3 times a day, 1 capsule in each time. The remaining 29 patients in the control group were treated with Hydergine orally, 3 times a day, 2 mg in each time. The therapeutic course for both groups was 2 months. The therapeutic effect in the treated group was significantly better than that in the control group, significant difference (P < 0.05 or P < 0.01) was shown in comparison of the two groups in terms of the mini-mental state examination (MMSE) and activity of daily living (ADL) test, symptoms scoring, total effective rate, and laboratory indexes findings. The therapeutic effect of YTC in treating VD was obvious.

MATERIALS
Product Number
Brand
Product Description

Codergocrine mesilate, European Pharmacopoeia (EP) Reference Standard
Pricing and availability is not currently available.